Abstract
Five dogs received a single 1.0 mg/kg dose of diazepam (DZ) IV. Concentrations of DZ and its major metabolite desmethyldiazepam (DMDZ) were simultaneously measured in plasma and cisternal cerebrospinal fluid (CSF) for up to 8 h after the dose by electron-capture gas-liquid chromatography. DZ was rapidly eliminated from plasma (half-life 0.3–1.3 h); DZ disappearance was mirrored by formation of DMDZ, which in turn was eliminated slowly. Both DZ and DMDZ rapidly penetrated CSF and concentrations in CSF declined parallel with those in plasma. Despite rapid uptake, the extent of CSF transfer of DZ and DMDZ was limited by plasma protein binding. Mean CSF: plasma concentration ratios for DZ (range 0.023–0.137) and DMDZ (range 0.047–0.119) were highly correlated with the unbound fraction in plasma (r=0.95 and 0.80, respectively). Thus DZ and DMDZ concentrations in CSF, presumed to reflect concentrations at the site of action, are determined by unbound plasma concentrations. The intensity of pharmacologic action is more likely to correlate with unbound than with total plasma concentrations.
Similar content being viewed by others
References
Danhof M, Breimer DD (1978) Therapeutic monitoring in saliva. Clin Pharmacokinet 3:39–57
Greenblatt DJ (1978) Simultaneous gas-chromatographic analysis of diazepam and its major metabolite, desmethyldiazepam, with use of double internal standardization. Clin Chem 24:1838–1841
Greenblatt DJ, Allen MD, Harmatz JS, Shader RI (1980) Diazepam disposition deteminants. Clin Pharmacol Ther 27:301–312
Greenblatt DJ, Shader RI, MacLeod SM, Sellers EM (1978) Clinical pharmacokinetics of chlordiazepoxide. Clin Pharmacokinet 3:381–394
Jalling B (1974) Plasma and cerebrospinal fluid concentrations of phenobarbital in infants given single doses. Dev med Child Neurol 16:781–793
Kangas L, Kanto J, Siirtola T, Pekkarinen A (1977) Cerebrospinal fluid concentrations of nitrazepam in man. Acta Pharmacol Toxicol (Kbh) 41:74–79
Kanto J, Kangas L, Siirtola T (1975) Cerebrospinal fluid concentrations of diazepam and its metabolites in man. Acta Pharmacol Toxicol (Kbh) 36:328–334
Klotz U, Antonin KH, Bieck PR (1976) Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. J Pharmacol Exp Ther 199:67–73
Koch-Weser J, Sellers EM (1976) Binding of drugs to serum albumin. N Engl J Med 294:311–316, 526–531
Leppik IE, Sherwin AL (1979) Intravenous phenytoin and phenobarbital: Anticonvulsant action, brain content, and plasma binding in rat. Epilepsia 20:201–207
Lund L, Berlin A, Lunde PKM (1972) Plasma protein binding of diphenylhydantoin in patients with epilepsy. Clin Pharmacol Ther 13:196–200
Mandelli M, Tognoni G, Garattini S (1978) Clinical pharmacokinetics of diazepam. Clin Pharmacokinet 3:72–91
Ochs HR, Greenblatt DJ, Lloyd BL, Woo E, Sonntag M, Smith TW (1980) Entry of quinidine into cerebrospinal fluid. Am Heart J (in press)
Oldendorf WH (1974) Blood-brain barrier permeability to drugs. Annu Rev Pharmacol 14:239–248
Ramsay HE, Hammond EJ, Perchalski RJ, Wilder BJ (1979) Brain uptake of phenytoin, phenobarbital, and diazepam. Arch Neurol 36:535–539
Rapoport SI (1976) Blood-brain barrier in physiology and medicine. Raven, New York
Schmidt D, Kupferberg HJ (1975) Diphenylhydantoin, phenobarbital, and primidone in saliva, plasma, and cerebrospinal fluid. Epilepsia 16:735–741
Schwartz MA, Koechlin BA, Postma E, Palmer S, Krol G (1965) Metabolism of diazepam in rat, dog, and man. J Pharmacol Exp Ther 149:423–435
Stanski DR, Greenblatt DJ, Selwyn A, Shader RI, Franke K, Koch-Weser J (1976) Plasma and cerebrospinal fluid concentrations of chlordiazepoxide and its metabolites in surgical patients. Clin Pharmacol Ther 20:571–578
Troupin AS, Friel P (1975) Anticonvulsant level in saliva, serum, and cerebrospinal fluid. Epilepsia 16:223–227
van der Kleijn E, van Rossum JM, Muskens ETJM, Rijntjes NVM (1971) Pharmacokinetics of diazepam in dogs, mice and humans. Acta Pharmacol Toxicol (Kbh) 29:109–127
Vree TB, Baars AM, Hekster YA, van der Kleijn E, O'Reilly WJ (1979) Simultaneous determination of diazepam and its metabolites N-desmethyldiazepam, oxydiazepam, and oxazepam in plasma and urine of man and dog by means of high performance liquid chromatography. J Chromatogr 162:605–614
Woo E, Greenblatt DJ (1979) Pharmacokinetic and clinical implications of quinidine protein binding. J Pharm Sci 68:466–470
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Greenblatt, D.J., Ochs, H.R. & Lloyd, B.L. Entry of diazepam and its major metabolite into cerebrospinal fluid. Psychopharmacology 70, 89–93 (1980). https://doi.org/10.1007/BF00432376
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00432376